| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 06/11/2009 | WO2009071444A2 Imaging method |
| 06/11/2009 | WO2009070847A1 Compounds for therapy and diagnosis |
| 06/11/2009 | WO2009036011A3 Markers for ventricular arrhythmia |
| 06/11/2009 | WO2009031890A3 A carrier particle for use in bio-applications |
| 06/11/2009 | WO2008151749A3 Activatable diagnostic and therapeutic compound |
| 06/11/2009 | WO2008076915A8 Treatment of pigs with pcv2 antigen |
| 06/11/2009 | WO2003038396A3 Method for detecting macromolecular conformational change and binding information |
| 06/11/2009 | US20090148884 Lat1 transporters expressed in blood brain barrier cells |
| 06/11/2009 | US20090148474 Determing virulence via replication and hybridization; immunogens |
| 06/11/2009 | US20090148387 Ultrasmall superparamagnetic iron oxide nanoparticles and uses thereof |
| 06/11/2009 | US20090148385 Ultrasound Contrast Agents For Molecular Imaging |
| 06/11/2009 | US20090148384 Functionalized, solid polymer nanoparticles comprising epothilones |
| 06/11/2009 | US20090148383 Anticoagulation Agent and Uses Thereof |
| 06/11/2009 | CA2706420A1 Compounds for therapy and diagnosis |
| 06/11/2009 | CA2702940A1 New non-selective somatostatin analogues |
| 06/10/2009 | EP2067861A1 Animals of the rattus genus wherein msh6 expression is functionally decreased and methods for the generation of specific mutants therefrom |
| 06/10/2009 | EP2067858A1 Animal models for neurodegenerative diseases |
| 06/10/2009 | EP2067786A1 Novel non selective analogs of somatostatin |
| 06/10/2009 | EP2067490A1 Chelating agent derivatives and compositions comprising the same for use in imaging methods |
| 06/10/2009 | EP2067489A1 Glyco-molecular imaging method for grade classification of liver fibrosis and its glyco-molecular imaging agent thereof |
| 06/10/2009 | EP2067485A1 Drug carrier providing MRI contrast enhancement |
| 06/10/2009 | EP2067480A1 Musclin receptor and use thereof |
| 06/10/2009 | EP2066357A2 T1 mri trackable drug delivery particles, uses and methods thereof |
| 06/10/2009 | EP2066339A2 Compositions and methods of enhancing immune responses |
| 06/10/2009 | EP1487499B1 Contrast agents for magnetic resonance imaging and methods related thereto |
| 06/10/2009 | CN101454026A Novel imaging agents |
| 06/10/2009 | CN100496615C Method of preparing ultrasonic contrast agent using mechanical oscillation |
| 06/09/2009 | US7544655 Novel amino acid sequences are within the carboxy termini of fibrinogen; useful for cell culture and cell separation |
| 06/04/2009 | WO2009070650A1 Small molecule cancer treatments that cause necrosis in cancer cells but do not affect normal cells |
| 06/04/2009 | WO2009070597A2 Fusion proteins for delivery of gdnf to the cns |
| 06/04/2009 | WO2009070552A1 Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes |
| 06/04/2009 | WO2009069833A1 Aza compounds and production method thereof, and metal complexes as mri contrast agents. |
| 06/04/2009 | WO2009069051A2 Non-spherical contrast agents for cest mri based on bulk magnetic susceptibility effect |
| 06/04/2009 | WO2009013115A3 Vesicles comprising a transmembrane transport trigger system |
| 06/04/2009 | WO2008141111A3 Polymers conjugated with platinum drugs |
| 06/04/2009 | WO2008141110A3 Polyglutamate conjugates and polyglutamate-amino acid conjugates having a plurality of drugs |
| 06/04/2009 | WO2008134734A3 Encapsulated contrast agents |
| 06/04/2009 | WO2006012586A3 Modulation of fiaf and the gastrointestinal microbiota |
| 06/04/2009 | US20090143685 Method and Apparatus for Detecting Diseases Associated with the Eye |
| 06/04/2009 | US20090142753 Compositions and methods for detecting compounds to treat a neurological disorder |
| 06/04/2009 | US20090142276 Alpha-fluoroalkyl dihydrotetrabenazine imaging agents and probes |
| 06/04/2009 | US20090142275 Wound Suture Capable of Identifying the Presence of Bacteria |
| 06/04/2009 | US20090142274 Intracellular nanosensors and methods for their introduction into cells |
| 06/04/2009 | US20090142272 Pfks as modifiers of the igfr pathway and methods of use |
| 06/04/2009 | US20090142271 Dendritic cells |
| 06/04/2009 | US20090142270 Prevention and treatment of cerebral amyloid angiopathy |
| 06/04/2009 | US20090142269 Isotoypically-labeled benzothiazole compounds as imaging agents for amyloidogenic proteins |
| 06/04/2009 | US20090142268 Chain-end functionalized poly(ethykene oxide) and process for the preparation of a nano-sized transition metal or metal salt using the same |
| 06/04/2009 | US20090142267 Fusogenic properties of saposin c and related proteins and peptides for application to tansmembrane drug delivery systems |
| 06/04/2009 | US20090142266 Peptides derived from maurocalcine used as vectors for intracellular addressing of molecules of interest |
| 06/04/2009 | US20090142262 Method of Diagnosing, Monitoring, Staging, Imaging and Treating Prostate Cancer |
| 06/04/2009 | US20090142260 In vivo detection of apoptosis |
| 06/04/2009 | DE102007058220A1 New metal complexes useful e.g. for manufacturing agent for X-ray diagnostics and magnetic resonance tomography-diagnostics of brain infarcts and liver tumor, and/or space-process in liver and abdomen tumors and musculoskeletal tumors |
| 06/03/2009 | EP2065058A1 Non-spherical contrast agents for CEST MRI based on bulk magnetic susceptibility effect |
| 06/03/2009 | EP2065057A2 Chelating conjugates having a substituted aromatic moiety and derivatives thereof |
| 06/03/2009 | EP2063916A2 X-ray contrast agent for post-mortem experimental and diagnostic angiography |
| 06/03/2009 | CN101448529A Magnetic resonance contrast medium using polyethylene glycol and magnetic resonance image pick-up method |
| 06/03/2009 | CN101444630A Method for preparing high magnetic resonance sensitivity ferroferric oxide nano-particle with tumor-targeting function |
| 06/03/2009 | CA2644729A1 Percutaneous devices for separating tissue, kits and methods of using the same |
| 06/02/2009 | US7542961 Method and system for analyzing drug adverse effects |
| 06/02/2009 | US7541447 Nucleotide sequence of the pgm gene of a Brucella bacterium modified by a partial or complete deletion of the sequence coding for phosphoglucomutase; live vaccine for immunization, prophylaxis or treatment of brucellosis comprises such a bacterium, either lyophilized or in a pharmaceutical vehicle |
| 06/02/2009 | US7541433 Transformed plant or fish cells with the isolated polynucleotide; wider array of colors and biochemical features compared to existing wild-type green fluorescent protein |
| 06/02/2009 | US7541140 Assessment of serum and/or urine calcium levels by determining the concentration of parathyroid hormone (PTH) agonist and that of PTH antagonist in a sample; comparingand averaging ratios; amino acid sequences of both; diagnosis/medical/; prognosis; metabolism/absorption of calcium calculi |
| 06/02/2009 | CA2249351C Novel method of diagnosing and treating gliomas |
| 05/28/2009 | WO2009067663A1 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds |
| 05/28/2009 | WO2009067105A1 Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same |
| 05/28/2009 | WO2009065230A1 Methods for detecting lung cancer and monitoring treatment response |
| 05/28/2009 | WO2009047655A3 Phase change visual indicating composition |
| 05/28/2009 | WO2008089248A3 Amphiphilic substances and triggered liberation from lipid vesicles |
| 05/28/2009 | US20090137494 Tumor-activated prodrug compounds and treatment |
| 05/28/2009 | US20090136980 screening for a therapeutic oligopeptide for treatment of tumor disorders; contacting the tumor with a therapeutically effective amount of a CD10 cleavable prodrug, wherein tumor is comprised of one or more target cells which express CD10 for at least a portion of the target cell life cycle |
| 05/28/2009 | US20090136428 High Throughput Genetic Screening Of Lipid And Cholesterol Processing Using Fluorescent Compounds |
| 05/28/2009 | US20090136427 LIGHT Inhibitors For Asthma, Lung and Airway Inflammation, Respiratory, Interstitial, Pulmonary and Fibrotic Disease Treatment |
| 05/28/2009 | US20090136426 Contrast media for using in medical and diagnostic procedures and methods of using the same |
| 05/28/2009 | US20090136425 Contrast agents |
| 05/28/2009 | US20090136424 Rotanone Analogs: Method of Preparation and Use |
| 05/28/2009 | US20090136423 Methods for assessing psychotic disorders |
| 05/28/2009 | US20090136417 Glycerol ester derivative having metal chelate structure |
| 05/28/2009 | US20090134331 Method of evaluating skin conditions and method of estimating skin thickness |
| 05/28/2009 | CA2705952A1 Methods for detecting lung cancer and monitoring treatment response |
| 05/27/2009 | EP2062600A1 CEST MRI contrast agents based on non-spherical particles |
| 05/27/2009 | EP2061814A2 Antibodies and immunoconjugates and uses therefor |
| 05/27/2009 | EP2061772A2 Multi-functional small molecules as anti-proliferative agents |
| 05/27/2009 | EP2061517A1 Gas-filled microvesicles with polymer-modified lipids |
| 05/27/2009 | EP1509246B1 Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis, and therapy |
| 05/27/2009 | CN101443029A Intraventricular protein delivery for amyotrophic lateral sclerosis |
| 05/27/2009 | CN101440126A Acquisition and use of homing polypeptide with targeting specificity related to tumor and metastases thereof |
| 05/27/2009 | CN101439191A Visible light induced zinc ion fluorescence angiographic reagent capable of being applied in cell/tissue/living body as well as synthesizing method and applications |
| 05/27/2009 | CN101439190A Cyclopenthiazide induced novel epilepsy model |
| 05/27/2009 | CN100491362C Biologically active methylene blue derivatives |
| 05/27/2009 | CN100490761C Dynamic inhalational contamination experimental instrument with solid-phase dust |
| 05/26/2009 | US7539528 Using magnetic resonance imaging to directly map neuronal activity |
| 05/26/2009 | US7538208 Expression vector comprising nucleotide sequences coding portion of ADP-ribosylating toxin for use treatment and prevention of gramnegative bacterial infection |
| 05/26/2009 | US7538195 Antibodies that bind to human insulin-like growth factor-I receptor; particularly, antibodies that inhibit the cellular functions of the IGF-I receptor; cancer treatment |
| 05/26/2009 | US7537909 Galactosidases; ultrafiltration; elution through columns; crystallization |
| 05/26/2009 | US7537788 Multilayer insert; radiopaque element, core, shell; controlling porosity of matrix |
| 05/26/2009 | CA2312614C In vivo biocompatible acoustic coupling media |
| 05/26/2009 | CA2146783C Preparation of further diagnostic agents |
| 05/22/2009 | WO2009064030A1 Photoacoustic imaging agent |
| 05/22/2009 | WO2009063995A1 Diagnosis and treatment of arteriosclerosis |